Deciphera Pharmaceuticals
Business

Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate Milestones

WALTHAM, Mass.–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate update and highlighted key 2022 milestones in conjunction with its […]